These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 10527248

  • 21. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
    Chow AW, Bartlett KH.
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
    [Abstract] [Full Text] [Related]

  • 22. Risk factors for an outbreak of multi-drug-resistant Acinetobacter nosocomial pneumonia among intubated patients.
    Husni RN, Goldstein LS, Arroliga AC, Hall GS, Fatica C, Stoller JK, Gordon SM.
    Chest; 1999 May; 115(5):1378-82. PubMed ID: 10334156
    [Abstract] [Full Text] [Related]

  • 23. Treatment of aspiration or tracheostomy-associated pneumonia in neurologically impaired children: effect of antimicrobials effective against anaerobic bacteria.
    Brook I.
    Int J Pediatr Otorhinolaryngol; 1996 Apr; 35(2):171-7. PubMed ID: 8735413
    [Abstract] [Full Text] [Related]

  • 24. [Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
    Zhang TQ, Dong L, Wang ZY, Li HY.
    Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):545-9. PubMed ID: 22088187
    [Abstract] [Full Text] [Related]

  • 25. [Phare study. Comparative study of combined cefepime-amikacin versus ceftazidime combined with amikacin in the treatment of nosocomial pneumonias in ventilated patients. Multicenter group study].
    Beaucaire G, Nicolas MH, Martin C, Offenstadt G, Philippon A, Holzapfel L, Péan Y, Léophonte P, Le Fur D, Renard S.
    Ann Fr Anesth Reanim; 1999 Feb; 18(2):186-95. PubMed ID: 10207592
    [Abstract] [Full Text] [Related]

  • 26. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, De Vos D, Simon A, Piérard D, Jacobs F, Dediste A, Tulkens PM, Van Bambeke F, Glupczynski Y.
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments.
    Souweine B, Veber B, Bedos JP, Gachot B, Dombret MC, Regnier B, Wolff M.
    Crit Care Med; 1998 Feb; 26(2):236-44. PubMed ID: 9468159
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia.
    Klekner A, Bagyi K, Bognar L, Gaspar A, Andrasi M, Szabo J.
    J Clin Microbiol; 2006 Sep; 44(9):3418-21. PubMed ID: 16954290
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide.
    Pfaller MA, Jones RN.
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):157-63. PubMed ID: 9327242
    [Abstract] [Full Text] [Related]

  • 32. [Guidelines for treatment of pneumonia in intensive care units].
    Emmi V.
    Infez Med; 2005 Aug; Suppl():7-17. PubMed ID: 16801748
    [Abstract] [Full Text] [Related]

  • 33. Colonization of lower respiratory tract with anaerobic bacteria in mechanically ventilated patients.
    Robert R, Grollier G, Frat JP, Godet C, Adoun M, Fauchère JL, Doré P.
    Intensive Care Med; 2003 Jul; 29(7):1062-8. PubMed ID: 12698243
    [Abstract] [Full Text] [Related]

  • 34. [Fluoroquinolones in antimicrobial therapy and prophylaxis in surgery].
    Vyhnánek F, Lochmann O.
    Rozhl Chir; 1995 Sep; 74(6):257-61. PubMed ID: 8658272
    [Abstract] [Full Text] [Related]

  • 35. Control of multi-resistant bacteria and ventilator-associated pneumonia: is it possible with changes in antibiotics?
    Jukemura EM, Burattini MN, Pereira CA, Braga AL, Medeiros EA.
    Braz J Infect Dis; 2007 Aug; 11(4):418-22. PubMed ID: 17873997
    [Abstract] [Full Text] [Related]

  • 36. [Evaluation of the effectiveness of ceftazidime in treatment of nosocomial infections in children].
    Czerwionka-Szaflarska M, Sobkowiak E.
    Pediatr Pol; 1996 Jul; 71(7):605-7. PubMed ID: 8803464
    [Abstract] [Full Text] [Related]

  • 37. [Specificity of the anaerobic bacterial infections in the surgical and orthopedic wards].
    Kierzkowska M, Majewska A, Sawicka-Grzelak A, Młynarczyk A, Ładomirska-Pestkowska K, Młynarczyk G.
    Med Dosw Mikrobiol; 2012 Jul; 64(1):29-34. PubMed ID: 22808727
    [Abstract] [Full Text] [Related]

  • 38. Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
    Jean SS, Teng LJ, Hsueh PR, Ho SW, Luh KT.
    J Antimicrob Chemother; 2002 Jan; 49(1):69-76. PubMed ID: 11751769
    [Abstract] [Full Text] [Related]

  • 39. Study of cefotaxime twice daily for the therapy of postoperative pneumonia. The German Cefotaxime Study Group.
    Bruch HP, Kujath P.
    Diagn Microbiol Infect Dis; 1995 Jan; 22(1-2):203-7. PubMed ID: 7587041
    [Abstract] [Full Text] [Related]

  • 40. Nosocomial pneumonia. Diagnostic and therapeutic considerations.
    Cunha BA.
    Med Clin North Am; 2001 Jan; 85(1):79-114. PubMed ID: 11190353
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.